P1295: ADVANTAGE OF FIRST-LINE TDM-DRIVEN USE OF INFLIXIMAB FOR TREATING ACUTE INTESTINAL AND LIVER GVHD IN CHILDREN: A PROSPECTIVE, SINGLE-CENTER STUDY.

Detalles Bibliográficos
Autores principales: Maximova, Natalia, Nistico’, Daniela, Marcuzzi, Annalisa, Rimondi, Erika, Tessitore, Antimo, Riccio, Guglielmo, Barbi, Egidio, Paolo, Antonello DI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430541/
http://dx.doi.org/10.1097/01.HS9.0000972068.73278.65

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430541/
http://dx.doi.org/10.1097/01.HS9.0000972068.73278.65

Ejemplares similares